Travere Therapeutics (TVTX) Change in Cash (2012 - 2026)
Travere Therapeutics (TVTX) posted Change in Cash of -$14.7 million for Q1 2026, up 18.01% on a QoQ basis from -$17.9 million in Q4 2025, and down 536.44% year-over-year from $3.4 million in Q1 2025.
Travere Therapeutics (TVTX) Change in Cash (2012 - 2026) Analysis & Trends
Travere Therapeutics' Change in Cash history runs 15 years deep, the most recent figure standing at -$14.7 million for Q1 2026.
- Quarterly Change in Cash fell 536.44% year-over-year to -$14.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $16.5 million (down 11.7% YoY) and the FY2025 annual result came in at $34.5 million, up 9510.03% from the prior year.
- Change in Cash was -$14.7 million for Q1 2026 at Travere Therapeutics, up from -$17.9 million in the prior quarter.
- Across five years, Change in Cash topped out at $99.7 million in Q1 2023 and bottomed at -$90.5 million in Q2 2023.
- A 5-year average of -$5.1 million and a median of -$11.0 million in 2024 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2022 — Change in Cash slumped 681.16% — and 2025, when it surged 768.77%.
- Travere Therapeutics' Change in Cash stood at -$89.6 million in 2022, then rose by 3.99% to -$86.1 million in 2023, then surged by 125.71% to $22.1 million in 2024, then plunged by 180.88% to -$17.9 million in 2025, then gained by 18.01% to -$14.7 million in 2026.
- Business Quant data shows TVTX's Change in Cash at -$14.7 million in Q1 2026, -$17.9 million in Q4 2025, and $35.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -22.03 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 243.78 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 417.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -153.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | Travere Therapeutics | 5.21 Bn | 5.21 Bn | 125.25 Mn | -14.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.67 Mn |
| Dec 31, 2025 | -17.90 Mn |
| Sep 30, 2025 | 35.78 Mn |
| Jun 30, 2025 | 13.26 Mn |
| Mar 31, 2025 | 3.36 Mn |
| Dec 31, 2024 | 22.13 Mn |
| Sep 30, 2024 | 4.12 Mn |
| Jun 30, 2024 | -10.96 Mn |
| Mar 31, 2024 | -14.93 Mn |
| Dec 31, 2023 | -86.07 Mn |
| Sep 30, 2023 | 73.37 Mn |
| Jun 30, 2023 | -90.50 Mn |
| Mar 31, 2023 | 99.69 Mn |
| Dec 31, 2022 | -89.65 Mn |
| Sep 30, 2022 | -28.42 Mn |
| Jun 30, 2022 | -76.81 Mn |
| Mar 31, 2022 | 90.82 Mn |
| Dec 31, 2021 | 15.43 Mn |
| Sep 30, 2021 | 67.04 Mn |
| Jun 30, 2021 | -64.94 Mn |